-
Track & Monitor
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q2 2017
The pharmaceutical and healthcare industry reported a decrease in the number of deals and deal values in Q2 2017 with 1,110 deals worth USD91.3 billion, as compared 1,224 worth USD163.8 billion in Q2 2016. On a quarter-on-quarter basis, the number of deals and deal values decreased in Q2 2017, when compared to 1,185 deals worth USD95.9 billion in Q1 2017. The pharmaceutical and healthcare industry reported a decrease in upfront payments in licensing agreements with USD725.3m in Q2 2017, as...
-
Track & Monitor
Partnerships, Licensing, Investments and M&A Deals and Trends for June 2017 in Pharmaceuticals
The pharmaceutical and healthcare industry reported a decrease in the number of deals and deal values in June 2017. The industry reported 353 deals worth USD31.7 billion in June 2017, compared to 375 deals worth USD36.8 billion in May 2017. The oncology therapeutics market remained at the top in deal activity in June 2017 with 126 deals. In second place, central nervous system therapeutics market reported 75 deals. Licensing agreements in pharmaceutical and healthcare industry registered a decrease in upfront...
-
Product Insights
Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H2, 2017" provides an overview of Exocrine Pancreatic Insufficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Exocrine Pancreatic Insufficiency. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Eisenmenger Syndrome Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Eisenmenger Syndrome Global Clinical Trials Review, H2, 2017" provides an overview of Eisenmenger Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Eisenmenger Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Cachexia Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Cachexia Global Clinical Trials Review, H1, 2017" provides an overview of Cachexia clinical trials scenario. This report provides top line data relating to the clinical trials on Cachexia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Axial Spondyloarthritis Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Axial Spondyloarthritis Global Clinical Trials Review, H1, 2017" provides an overview of Axial Spondyloarthritis clinical trials scenario. This report provides top line data relating to the clinical trials on Axial Spondyloarthritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Celiac Disease Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Celiac Disease Global Clinical Trials Review, H1, 2017" provides an overview of Celiac Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Celiac Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Cerebral Palsy Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Cerebral Palsy Global Clinical Trials Review, H1, 2017" provides an overview of Cerebral Palsy clinical trials scenario. This report provides top line data relating to the clinical trials on Cerebral Palsy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Cystitis Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Cystitis Global Clinical Trials Review, H2, 2017" provides an overview of Cystitis clinical trials scenario. This report provides top line data relating to the clinical trials on Cystitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H2, 2017" provides an overview of Deep Vein Thrombosis (DVT) clinical trials scenario. This report provides top line data relating to the clinical trials on Deep Vein Thrombosis (DVT). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...